BR112019011303B1 - Derivados de ácido hidroxibenzoico, métodos e usos dos mesmos - Google Patents

Derivados de ácido hidroxibenzoico, métodos e usos dos mesmos Download PDF

Info

Publication number
BR112019011303B1
BR112019011303B1 BR112019011303-7A BR112019011303A BR112019011303B1 BR 112019011303 B1 BR112019011303 B1 BR 112019011303B1 BR 112019011303 A BR112019011303 A BR 112019011303A BR 112019011303 B1 BR112019011303 B1 BR 112019011303B1
Authority
BR
Brazil
Prior art keywords
mitochondrial
aryl
chain
alkyl
cancer
Prior art date
Application number
BR112019011303-7A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112019011303A2 (pt
Inventor
Maria Fernanda Martins Borges
Paulo Jorge Gouveia Simões Da Silva Oliveira
José Carlos Santos Teixeira
Fernando Cagide Fagin
Ana Catarina Gomes Oliveira
Original Assignee
Centro De Neurociências E Biologia Celular
Universidade Do Porto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Neurociências E Biologia Celular, Universidade Do Porto filed Critical Centro De Neurociências E Biologia Celular
Publication of BR112019011303A2 publication Critical patent/BR112019011303A2/pt
Publication of BR112019011303B1 publication Critical patent/BR112019011303B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112019011303-7A 2016-12-29 2017-12-29 Derivados de ácido hidroxibenzoico, métodos e usos dos mesmos BR112019011303B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT109818 2016-12-29
PT10981816 2016-12-29
PCT/IB2017/058508 WO2018122789A1 (en) 2016-12-29 2017-12-29 Hydroxybenzoic acid derivatives, methods and uses thereof

Publications (2)

Publication Number Publication Date
BR112019011303A2 BR112019011303A2 (pt) 2019-10-08
BR112019011303B1 true BR112019011303B1 (pt) 2023-03-14

Family

ID=61074472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019011303-7A BR112019011303B1 (pt) 2016-12-29 2017-12-29 Derivados de ácido hidroxibenzoico, métodos e usos dos mesmos

Country Status (8)

Country Link
US (1) US11078222B2 (cg-RX-API-DMAC7.html)
EP (1) EP3562830B1 (cg-RX-API-DMAC7.html)
JP (2) JP2020503280A (cg-RX-API-DMAC7.html)
KR (1) KR102750630B1 (cg-RX-API-DMAC7.html)
CN (1) CN110114365B (cg-RX-API-DMAC7.html)
BR (1) BR112019011303B1 (cg-RX-API-DMAC7.html)
CA (1) CA3048966A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018122789A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2023053059A1 (en) * 2021-09-30 2023-04-06 Universidade Do Porto Antifouling compound, method and uses thereof
WO2023220365A1 (en) * 2022-05-13 2023-11-16 Virginia Tech Intellectual Properties, Inc. Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders
US20260097092A1 (en) * 2022-09-21 2026-04-09 Ulsan National Institute Of Science And Technology Pharmaceutical composition containing mitochondria-targeting compound as active ingredient for treating macular degeneration
KR102894216B1 (ko) * 2022-12-15 2025-12-18 울산과학기술원 Trap-1 억제제
CN116210697B (zh) * 2023-03-02 2024-05-14 西北农林科技大学 反式肉桂酸在提高苹果树腐烂病抗性中的应用
KR20250126454A (ko) * 2024-02-16 2025-08-25 울산과학기술원 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2860266C (en) 2009-04-27 2017-10-31 Iowa State University Research Foundation, Inc. Neuroprotective compounds and their use
GB201320636D0 (en) * 2013-11-22 2014-01-08 Medical Res Council Compounds
MX2018010829A (es) * 2016-03-08 2019-02-07 Univ Michigan Regents Inductores de molécula pequeña de especies de oxígeno reactivo e inhibidores de la actividad mitocondrial.
US10913757B2 (en) * 2016-10-14 2021-02-09 Universidade Do Porto Hydroxycinnamic derivatives, methods and uses thereof

Also Published As

Publication number Publication date
US11078222B2 (en) 2021-08-03
KR20190132622A (ko) 2019-11-28
JP2020503280A (ja) 2020-01-30
EP3562830A1 (en) 2019-11-06
WO2018122789A1 (en) 2018-07-05
JP2023051961A (ja) 2023-04-11
JP7689690B2 (ja) 2025-06-09
CN110114365B (zh) 2022-12-13
KR102750630B1 (ko) 2025-01-06
CA3048966A1 (en) 2018-07-05
BR112019011303A2 (pt) 2019-10-08
EP3562830B1 (en) 2023-06-07
US20190330249A1 (en) 2019-10-31
EP3562830C0 (en) 2023-06-07
CN110114365A (zh) 2019-08-09

Similar Documents

Publication Publication Date Title
JP7689690B2 (ja) ヒドロキシ安息香酸誘導体、その方法および使用
JP7111730B2 (ja) ヒドロキシケイ皮酸誘導体、その方法および使用
Teixeira et al. Development of hydroxybenzoic-based platforms as a solution to deliver dietary antioxidants to mitochondria
CA2826034A1 (en) Stilbene analogs and methods of treating cancer
ES2857196T3 (es) Composiciones y métodos para tratar trastornos médicos relacionados con estrógenos
JP2016506929A (ja) ヒト銅輸送タンパク質atox1およびccsを阻害するための方法および組成物
Bai et al. Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs
KR20150120424A (ko) 백혈병의 치료방법 및 치료용 조성물
EP2956140A1 (en) Neuroprotective multifunctional antioxidants and their monofunctional analogs
JP2017075178A (ja) 抗癌治療剤のタンパク質ターゲットとしてのオキシドスクアレンシクラーゼ
JP2011516473A (ja) 医薬組成物
Xiao et al. Cardioprotection of (±)-sodium 5-bromo-2-(α-hydroxypentyl) benzoate (BZP) on mouse myocardium I/R injury through inhibiting 12/15-LOX-2 activity
EP2522394B1 (en) Substituted phosphonates and their use decreasing amyloid aggregates
CA2717511A1 (en) Modulation of enzymatic structure, activity, and/or expression level
Plaza et al. Inhibitory effect of nordihydroguaiaretic acid and its tetra-acetylated derivative on respiration and growth of adenocarcinoma TA3 and its multiresistant variant TA3MTX-R
EP2909171B1 (fr) Composés 3,4-bis(catéchol)pyrrole n-substitués, leur préparation et utilisation dans le traitement du cancer
BR112019007565B1 (pt) Derivados hidroxicinâmicos, métodos e usos dos mesmos
EP3353186B1 (en) Highly efficient nrf2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation
JP2025535717A (ja) ミトコンドリア標的n-アセチルシステインおよび類似体
WO2020226520A1 (en) A new terpenoid derivative and its use in chemoprevention and supporting cancer chemotherapy

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/12/2017, OBSERVADAS AS CONDICOES LEGAIS